Inventaire - your friends and communities are your best library

Patient-centric trials for therapeutic development in precision oncology.

Author

Andrew Biankin

Steven T. Piantadosi

published in: Nature

date of publication: 2015-10-01

language: anglais

main subject: patient

Bibliographic databases:

Cites articles 56

Date

Title

Authors

2001-03-01

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment
2002-08-01

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

, , , , , , , ,
2004-09-01

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

, , , , , , ,
2005-03-01

Clinical trial designs for predictive marker validation in cancer treatment trials

,
2008-04-01

Translating insights from the cancer genome into clinical practice

,
2008-10-23

Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2009-04-09

The cancer genome

,
2009-07-13

Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges
2009-07

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy
2009-01

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
2009-06-01

Molecular biomarkers to individualise treatment: assessing the evidence
2010-04-01

International network of cancer genome projects

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
2010-12-01

ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time
2010-06-24

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR
2010-10-04

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
2010-06-10

Envisioning the future of early anticancer drug development.
2011-03-01

Exploring the genomes of cancer cells: progress and promise
2011-10-01

Adjuvant trastuzumab in HER2-positive breast cancer

, , , , , , , , , , , , , ,
2011-02-01

Charting a course for genomic medicine from base pairs to bedside

,
2011-06-01

The BATTLE trial: personalizing therapy for lung cancer

, , , , , ,
2011-12-25

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).

, , , , , , ,
2011-07-28

Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial).

, , ,
2011-06-05

Somatic variation and cancer: therapies lost in the mix.
2011-03-01

Cancer genomics: from discovery science to personalized medicine

,
2012-02-23

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

, , , , , , , , ,
2012-09-10

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

, , ,
2012-06-21

Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trials

, , , ,
2012-05-29

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

, , , , , ,
2012-06-01

Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

, ,
2012-11-17

Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial

, , , ,
2013-06-01

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer

, , , , , , , ,
2013-04-15

Designing transformative clinical trials in the cancer genome era.

Article -

Welcome to Inventaire

the library of your friends and communities

learn more